Current and potential contributions of community pharmacy teams to self-harm and suicide prevention: A qualitative interview study

Autoři: Hayley C. Gorton aff001;  Donna Littlewood aff002;  Christine Lotfallah aff001;  Matthew Spreadbury aff001;  Kai Ling Wong aff001;  Patricia Gooding aff004;  Darren M. Ashcroft aff001
Působiště autorů: Division of Pharmacy & Optometry, School of Health Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom aff001;  NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom aff002;  School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom aff003;  Division of Psychology & Mental Health, School of Health Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom aff004
Vyšlo v časopise: PLoS ONE 14(9)
Kategorie: Research Article
doi: 10.1371/journal.pone.0222132



Suicide prevention is a global priority. Despite the focus on primary care in suicide prevention, little is known about the contributory role of community pharmacists and nothing about the role of the wider community pharmacy team in this area. We aimed to explore the current and potential role of community pharmacy teams in self-harm and suicide prevention.


We conducted one-to-one semi-structured qualitative interviews with community pharmacy staff (pharmacists, pre-registration pharmacists, pharmacy technicians, dispensing/pharmacy assistants, delivery drivers) in the North West of England, UK. We identified themes from the interview transcripts through an iterative process of inductive thematic analysis.


We conducted twenty-five interviews with community pharmacy staff. Many described examples of helping those who were contemplating suicide or self-harm. No participants had received suicide prevention training. We identified six themes. The first two themes (i) Relationship with Patient and (ii) Pharmacy environment were seen as facilitators, which, if supported by (iii) Training, could underpin the final three themes: (iv) Opportunities for contact, (v) Facilitated referral pathway and (v) Restricting access to means. The distinct lack of training should be overcome with evidence-informed training. Referral pathways should be clear and enable direct and accessible referral by community pharmacy teams. There are opportunities for existing pharmacy services and schemes to be adapted to maximise suicide and self-harm prevention activities. Pharmacy teams did not identify themselves to have a clear role in restricting access to medication.


Pharmacy teams already support patients in relation to self-harm and suicide, often relying on their personal experience in the absence of formal training. With the implementation of evidence-informed training and clear referral pathways, this could be done in a more effectively.

Klíčová slova:

Medicine and health sciences – Mental health and psychiatry – Suicide – Self harm – Health care – Patients – Pharmacology – Drug research and development – Diagnostic medicine – Signs and symptoms – Poisoning – Pathology and laboratory medicine – People and places – Population groupings – Professions – Medical personnel – Pharmacists – Research and analysis methods – Research design – Qualitative studies


1. World Health Organization. Preventing suicide A global imperative. Geneva: World Health Organisation; 2014.

2. Office for National Statistics. Suicides in the UK. Newport: Office for National Statistics; 2018.

3. The Mental Health Taskforce. The five year forward view for mental health. London: NHS England; 2016.

4. HM Government. Preventing suicide in England: Third progress report on the cross-government outcomes strategy to save lives. London: HM Government; 2017.

5. Health Select Committee. Suicide prevention. London: House of Commons; 2017.

6. Public Health England. Local suicide prevention planning. London: Public Health England; 2016.

7. Scottish Government. Scotland’s Suicide Prevention Action Plan: Every Life Matters. Edinburgh: Scottish Government; 2018.

8. National Collaborating Centre for Mental Health. Self-harm and Suicide Prevention Competence Framework: Adults and older adults. London: National Collaborating Centre for Mental Health; 2018.

9. Pharmaceutical Services Negotiating Committee. About community pharmacy [Internet]. 2018 [cited 16 Oct 2018]. Available from:

10. The National Health Service Act 2006. The Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions 2013, (2006).

11. NHS England. Quality Payments: Guidance for the February 2019 Review Point. London: NHS England; 2018.

12. National Institute for Health and Care Excellence and Public Health England. NG105 Preventing suicide in community and custodial settings. London: National Institute for Health and Care Excellence; 2018.

13. Murphy A, Hillier K, Ataya R, Thabet P, Whelan A, O’Reilly C et al. A scoping review of community pharmacists and patients at risk of suicide. Can Pharm J(Ott). 2017;150:366–79.

14. Murphy A, Ataya R, Himmelman D, O’Reilly C, Rosen A, Salvador-Carulla L et al. Community pharmacists’ experiences and people at risk of suicide in Canada & Australia: a thematic analysis. Soc Psychiatry Psychiatr Epidemiol. 2018; 53(11):1173–84. doi: 10.1007/s00127-018-1553-7 29936597

15. Carpenter D, Lavigne J, Colmenares E, Falbo K, Mosley S. Community pharmacy staff interactions with patients who have risk factors or warning signs of suicide. Res Soc Adm Pharm. 2019;[in press].

16. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.

17. Boyatzis R. Transforming qualitative information: Thematic analysis and code development. London: Sage; 1998.

18. Samaritans. Suicide reporting-additional points to consider [Internet]. 2016 [cited 21 Jan 2019]. Available from:

19. Murphy AL, Gardner DM, Jacobs LM. Patient care activities by community pharmacists in a capitation funding model mental health and addictions program. BMC Psychiatry. 2018;18(1):192. doi: 10.1186/s12888-018-1746-3 29898682

20. Hindi AM, Schafheutle EI, Jacobs S. Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review. Health Expect. 2018;21(2):409–28. doi: 10.1111/hex.12639 29114971

21. GPhC. Future Pharmacists: Standards for the initial education and training of pharmacists. London: GPhC; 2011.

22. Carpenter D, Lavigne J, Roberts C, Zacher J, Colmenares EW. A Review of Suicide Prevention Programs and Training Policies for Pharmacists. J Am Pharm Assoc. 2018;58(5):522–29.

23. Matt Adler suicide assessment, treatment, and management training act of 2012, (2012)

24. Leavey G, Mallon S, Rondon-Sulbara J, Galway K, Rosato M, Hughes L. The failure of suicide prevention in primary care: family and GP perspectives—a qualitative study. BMC Psychiatry. 2017;17:369. doi: 10.1186/s12888-017-1508-7 29157221

25. Murray R. Community Pharmacy Clinical Services Review. London: Kings Fund; 2016.

26. Anderson C, Kirkpatrick S, Ridge D, Kokanovic R, Tanner C. Starting antidepressant use: a qualitative synthesis of UK and Australian data. BMJ Open. 2015;5(12).

27. Firth H, Todd A, Bambra C. Benefits and barriers to the public health pharmacy: a qualitative exploration of providers’ and commissioners’ perceptions of the Healthy Living Pharmacy framework. Perspect Public Health. 2015;135(5):251–56. doi: 10.1177/1757913915579457 25868465

28. Lavigne JE, King DA, Lu NJ, Knox KL, Kemp JE. Pharmacist and pharmacy staff knowledge, attitudes and motivation to refer patients for suicide risk assessment: lessons from operation S.A.V.E. In: Lavigne JE, editor. Frontiers in Suicide Risk. US: Nova Science Publishers, Inc; 2012.

29. Murphy AL, O’Reilly CL, Ataya R, Doucette SP, Martin-Misener R, Rosen A et al. A survey of Canadian and Australian pharmacists’ stigma of suicide. SAGE Open Med. 2019;7:2050312118820344. doi: 10.1177/2050312118820344 30728964

30. Carrr MJ, Ashcroft DM, Kontopantelis E, Awenat Y, Cooper J, Chew-Graham C et al. The epidemiology of self-harm in a UK-wide primary care patient cohort, 2001–2013. BMC Psychiatry. 2016;16(1).

31. NHS England. Hospital Accident and Emergency Activity—2017–18 [Internet]. 2018 [cited 22 Sept 2018]. Available from:

32. Office for National Statistics. Deaths related to drug poisoning in England and Wales: 2017 registrations. Newport: Office for National Statistics; 2018

Článek vyšel v časopise


2019 Číslo 9

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Zvyšte si kvalifikaci online z pohodlí domova

Ulcerative colitis_muž_břicho_střeva
Ulcerózní kolitida
nový kurz

Blokátory angiotenzinových receptorů (sartany)
Autoři: MUDr. Jiří Krupička, Ph.D.

Antiseptika a prevence ve stomatologii
Autoři: MUDr. Ladislav Korábek, CSc., MBA

Citikolin v neuroprotekci a neuroregeneraci: od výzkumu do klinické praxe nejen očních lékařů
Autoři: MUDr. Petr Výborný, CSc., FEBO

Zánětlivá bolest zad a axiální spondylartritida – Diagnostika a referenční strategie
Autoři: MUDr. Monika Gregová, Ph.D., MUDr. Kristýna Bubová

Všechny kurzy